Table 2. Distribution of demographic and clinical variables based on AF and diagnosis group.
| Controls | Adenoma | CRC | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AF- | AF+ | P value | AF- | AF+ | P value | AF- | AF+ | P value | |
| n = 691 | n = 40 | n = 935 | n = 73 | n = 474 | n = 53 | ||||
| Age, median (IQR) | 55 (48–68) | 68 (53–78) | <0.001 | 65 (56–76) | 75 (64–82) | <0.001 | 66 (57–78) | 75 (64–82) | <0.001 |
| Male gender (%) | 354 (51%) | 21 (53%) | 0.9 | 468 (50%) | 34 (47%) | 0.6 | 218 (46%) | 28 (53%) | 0.3 |
| Diabetes (%) | 205 (30%) | 11 (28%) | 0.8 | 935 (32%) | 18 (25%) | 0.2 | 154 (32%) | 24 (45%) | 0.062 |
| HTN (%) | 344 (50%) | 24 (60%) | 0.2 | 488 (52%) | 40 (55%) | 0.7 | 270 (57%) | 40 (75%) | 0.009 |
| Heart Failure (%) | 79 (11%) | 16 (40%) | <0.001 | 103 (11%) | 31 (42%) | <0.001 | 51 (11%) | 27 (51%) | <0.001 |
| Alcohol (%) | 120 (17%) | 5 (13%) | 0.4 | 102 (11%) | 9 (12%) | 0.7 | 56 (12%) | 7 (13%) | 0.8 |
| Tobacco (%) | 220 (32%) | 5 (13%) | 0.010 | 234 (25%) | 17 (23%) | 0.7 | 133 (28%) | 14 (26%) | 0.8 |
| Number of hospital admissions, median(IQR) | 1 (1–2) | 1 (1–2) | 0.7 | 1 (1–2) | 1 (1–1) | 0.007 | 1 (1–1) | 1 (1–2) | 0.3 |